Analyst Research

Report Title Price
Provider: Reuters Investment Profile
$20.00
Provider: GlobalData
$125.00
Provider: GlobalData
$125.00
Provider: Wright Reports
$426.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

NASDAQ OMX Riga Cancels Trading under Surveillance for Rigas Farmaceitiska Fabrika AS-NASDAQ OMX Riga


Wednesday, 9 May 2012 08:17am EDT 

NASDAQ OMX Riga announced that its Management Board has resolved to cancel the trading under surveillance for Rigas Farmaceitiska Fabrika AS, with immediate effect. Rigas Farmaceitiska Fabrika AS has published, on May 8, 2012, the audited annual report for 2011 in Latvian and on May 9, 2012 in English. Thus, the circumstances that were the reason for trading under surveillance since May 2, 2012 have ceased to exist. 

Company Quote

1.02
0.187 +22.45%
14 Apr 2014